Savara
SVRA
#6062
Rank
A$1.41 B
Marketcap
A$6.92
Share price
-3.70%
Change (1 day)
36.73%
Change (1 year)

Earnings for Savara (SVRA)

Earnings in 2025 (TTM): -A$0.19 Billion

According to Savara's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$0.14 Billion a decrease over its 2023 earnings that were of -A$76.43 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara from 2002 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.19 Billion34.58%
2024 -A$0.14 Billion75.29%
2023 -A$76.43 Million43.38%
2022 -A$53.31 Million-11.31%
2021 -A$60.11 Million-13.3%
2020 -A$69.33 Million-36.53%
2019 -A$0.11 Billion13.76%
2018 -A$96.02 Million105.54%
2017 -A$46.72 Million34.11%
2016 -A$34.84 Million-37.43%
2015 -A$55.68 Million38.81%
2014 -A$40.11 Million33.62%
2013 -A$30.02 Million38.49%
2012 -A$21.68 Million24.59%
2011 -A$17.4 Million-36.5%
2010 -A$27.4 Million-3.14%
2009 -A$28.29 Million-23.28%
2008 -A$36.87 Million8.52%
2007 -A$33.97 Million-34.14%
2006 -A$51.59 Million184.43%
2005 -A$18.14 Million90.75%
2004 -A$9.51 Million190.35%
2003 -A$3.28 Million11.64%
2002 -A$2.94 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-A$0.23 Billion 37.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-A$25.37 Million-84.30%๐Ÿ‡บ๐Ÿ‡ธ USA